Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Point implant system

K-Number: K222738 · 2023-04-13

Decision Date2023-04-13
Product CodeDZE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Point implant system is a medical device manufactured by Pointnix Co., Ltd.. It received FDA 510(k) clearance on 2023-04-13 under approval number K222738. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Point implant system?

Point implant system is a medical device that received FDA 510(k) clearance on 2023-04-13. It is manufactured by Pointnix Co., Ltd.. The 510(k) number is K222738.

When was Point implant system approved by the FDA?

Point implant system received FDA 510(k) clearance on 2023-04-13, under approval number K222738.

What company makes Point implant system?

Point implant system is manufactured by Pointnix Co., Ltd..

What is the FDA product code for Point implant system?

The FDA product code for Point implant system is DZE.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: DZE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.